首页> 美国卫生研究院文献>Pathology Research International >Association between AgNORs and Immunohistochemical Expression of ER PR HER2eu and p53 in Breast Carcinoma
【2h】

Association between AgNORs and Immunohistochemical Expression of ER PR HER2eu and p53 in Breast Carcinoma

机译:AgNORs与乳腺癌中ERPRHER2 / neu和p53免疫组织化学表达的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Settings. Despite the limited diagnostic utility of AgNORs (argyrophilic nucleolar organiser region-associated proteins) for individual breast lesions, AgNOR analysis bears a significant potential for characterizing cell proliferative activity of breast lesions. Methodology. The present study investigated the relationship between mean AgNORs count and immunohistochemical expression of ER, PR, HER2eu, and p53 in breast carcinoma in serial paraffin sections from 137 breast carcinomas. Twenty control cases of benign breast lesions were included. Results. Mean AgNOR counts correlated significantly inversely with hormone estrogen receptors (ER), Progesterone receptors (PR), and p53 immunohistochemical expression, denoting P values of 0.05, 0.01, and 0.001, respectively. No significant correlation was found between mean AgNOR counts and HER2eu, P = 0.9. Mean AgNOR count was significantly higher in grade II tumor cells. We conclude that mean AgNOR counts correlate with ER, PR, and P53 tumor markers in breast carcinomas. Conclusion. We recommend the use of mean AgNOR count for accurate reporting of breast carcinomas, as well as prediction of ER, PR, and P53 in routine paraffin sections.
机译:设定尽管AgNORs(嗜银性核仁组织者区域相关蛋白)对单个乳腺病变的诊断功能有限,但AgNOR分析仍具有表征乳腺病变细胞增殖活性的巨大潜力。方法。本研究调查了137例乳腺癌的连续石蜡切片中AgNORs平均计数与ER,PR,HER2 / neu和p53的免疫组织化学表达之间的关系。包括20例乳腺良性病变的对照病例。结果。 AgNOR平均计数与激素雌激素受体(ER),孕激素受体(PR)和p53免疫组化表达显着负相关,分别表示P值为0.05、0.01和0.001。平均AgNOR计数与HER2 / neu之间未发现显着相关性,P = 0.9。在II级肿瘤细胞中,平均AgNOR计数显着更高。我们得出结论,平均AgNOR计数与乳腺癌中的ER,PR和P53肿瘤标志物相关。结论。我们建议使用平均AgNOR计数来准确报告乳腺癌,并在常规石蜡切片中预测ER,PR和P53。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号